A Stanford physician argues pregnant women should be appropriately included in clinical research to improve their health and the health of their fetuses.
Tag: clinical trials
Immunotherapy for peanut allergies: A Q&A
Sharon Chinthrajah weighs in on a new peanut allergy immunotherapy, speaking to its potential and its role in the future of food allergies therapy.
Beating cancer’s wildfire while the flames rage
A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.
New hope for a drug to treat lymphedema symptoms
The anti-inflammatory drug ketoprofen shows promise as effective medical treatment for lymphedema symptoms, small Stanford study finds
Understanding and predicting deception in clinical trials
A new Stanford-led study catalogs the prevalence and types of deception by volunteers in clinical trials and suggests ways for investigators to root it out.
Most clinical trial participants find benefits of sharing personal data outweigh risks
Most participants in clinical trials believe the benefits of broadly sharing individual data outweigh the risks, a new Stanford study has found.
The efficacy of antidepressants: A Q&A with John Ioannidis
In a meta-analysis of more than 500 clinical trials, researchers have new conclusions about the efficacy of 21 different antidepressants.
Project Baseline study enrolls 100th Stanford volunteer — additional participants needed
The Project Baseline study is an ambitious endeavor with a potentially transformative payoff. Launched in April after years of designing and planning by Verily, an Alphabet …
Health Policy Forum considers whether, and how, to share clinical trial data
Should data from clinical trials be available to all? Or just for certain investigations? Who decides? And how would that work? These, and a host …
At Big Data in Biomedicine, reexamining clinical trials in the era of precision health
Clinical trials, in their current incarnation, are ill-suited for the nimble, personalized precision health era, a a panel of speakers at the Big Data in …
The future of clinical trials considered during Dean’s Lecture Series address
A number of changes could affect the future of clinical trials, including the increased involvement of health-care providers, said Thomas Pike, the former CEO of …
“Off-the-charts dangerous”: Sham stem cell trial at Florida clinic blinds three women
I can summarize a recent press release I wrote about an unproven stem cell treatment in three words: sad, shocking and sobering. Three women with …
Cancer clinical trials: Stanford strives to enroll more diverse participants
In a previous post, I described why I enrolled in a clinical trial at Stanford to treat my Hodgkin’s lymphoma. But I didn’t share the …
Cancer clinical trials: Why I chose to participate, but so many others don’t
When I was 29 years old, I was one of the healthiest people I knew. I biked 10 miles to work, played ultimate frisbee, slept …
When medical knowledge is at a crossroads, how research can take patient preferences into account
Let's say you have high blood pressure that can be treated with one of two medications. Neither drug is experimental; both are within the standard …
How one statistician is refining clinical trials
Biomed Bites is back. It's a weekly feature that introduces readers to some of Stanford's most innovative biomedical researchers. A love of mathematics propelled Ying Lu, …